Managing Blood Thinners Before High-Risk Surgery
Part of Heart & circulation clinical trials.
This study looks at how to safely manage your blood thinner (DOAC) around the time of a planned, high-bleed-risk surgery or procedure involving a spinal needle. The goal is to find the best way to stop and restart your medication to prevent bleeding and clotting problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You take a full dose of one of these blood thinners: apixaban (Eliquis), dabigatran (Pradaxa), edoxaban (Savaysa/Lixiana), or rivaroxaban (Xarelto).
- You take it for atrial fibrillation (a type of irregular heartbeat) or for a blood clot in your leg or lung.
- You have a planned surgery or procedure that has a high risk of bleeding, or that involves a spinal needle (epidural, spinal block).
- You do not have severe kidney problems, and you are able to give consent and stay in contact for follow-up.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the safety of managing blood thinners (like apixaban or warfarin) around the time of cancer surgery or procedures. It aims to help doctors understand how to best handle these medications to reduce risks.
This study looks at whether a virtual visit can safely manage your blood thinners around the time of a planned surgery. You would stop your medication before the procedure and restart it after, but all instructions and check-ins happen remotely (phone or video).
This study tests whether patients with atrial fibrillation (a heart rhythm disorder) who have had both a previous brain bleed and a recent stroke can safely take blood thinners to prevent future strokes. Researchers want to find the safest approach for people in this high-risk situation.
This trial compares two types of blood thinners (DOACs like apixaban or rivaroxaban, and warfarin) to see which works better for people who have a stroke while taking a DOAC. The goal is to find the safest and most effective option to prevent another stroke.
This study compares whether you should temporarily stop your blood thinner (DOAC) or keep taking it when you have an elective heart catheter test or procedure (coronary angiography or PCI). It aims to see which approach is safer and better for preventing bleeding and clotting around the procedure.
This trial studies how safely and effectively to pause a blood thinner (a DOAC) for about 48 hours before an elective procedure in people with atrial fibrillation. It may help confirm the best way to reduce bleeding risk without raising stroke risk.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.